 Livemint | Compulsory licences may spur more voluntary licensing deals Livemint India issued its first compulsory licence in February last year, allowing Hyderabad-based Natco Pharma Ltd to make Bayer AG's lung and kidney cancer drug Nexavar at one-tenth the price. The drug cost Rs.2.80 lakh for a month's treatment, although Bayer ... |
